290 related articles for article (PubMed ID: 19918335)
21. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
[TBL] [Abstract][Full Text] [Related]
22. Nonhepatosplenic gamma delta T-cell lymphoma with initial testicular compromise.
Scolnik MP; Burgos RA; Paz A; Weinreiter M; del Carmen Ardaiz M; Bare P; Hanza MC; de Dios Soler MA; Narbaitz MI; Palacios MF; Sasot A; Huberman A; de Bracco MM
Am J Hematol; 2000 Nov; 65(3):260-2. PubMed ID: 11074546
[TBL] [Abstract][Full Text] [Related]
23. Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression.
Song W; Zhang H; Yang F; Nakahira K; Wang C; Shi K; Zhang R
Cell Oncol (Dordr); 2023 Feb; 46(1):211-226. PubMed ID: 36417130
[TBL] [Abstract][Full Text] [Related]
24. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.
Salhany KE; Feldman M; Kahn MJ; Peritt D; Schretzenmair RD; Wilson DM; DiPaola RS; Glick AD; Kant JA; Nowell PC; Kamoun M
Hum Pathol; 1997 Jun; 28(6):674-85. PubMed ID: 9191001
[TBL] [Abstract][Full Text] [Related]
25. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
[TBL] [Abstract][Full Text] [Related]
27. Peripheral CD4+ CD8- gammadelta T cell lymphoma: a case report with multiparameter analyses.
Ichinohasama R; Miura I; Takahashi T; Yaginuma Y; Myers J; DeCoteau JF; Yee C; Kadin ME; Mori S; Sawai T
Hum Pathol; 1996 Dec; 27(12):1370-7. PubMed ID: 8958314
[TBL] [Abstract][Full Text] [Related]
28. Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
[TBL] [Abstract][Full Text] [Related]
29. Rare variety of T-cell lymphoma.
Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
[TBL] [Abstract][Full Text] [Related]
30. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.
Macon WR; Levy NB; Kurtin PJ; Salhany KE; Elkhalifa MY; Casey TT; Craig FE; Vnencak-Jones CL; Gulley ML; Park JP; Cousar JB
Am J Surg Pathol; 2001 Mar; 25(3):285-96. PubMed ID: 11224598
[TBL] [Abstract][Full Text] [Related]
31. Hepatosplenic T-cell lymphoma: A case series.
Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
[TBL] [Abstract][Full Text] [Related]
33. Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.
Calvaruso M; Gulino A; Buffa S; Guarnotta C; Franco G; Cacciatore M; Bonura MG; Franco V; Florena AM
Leuk Lymphoma; 2014 Nov; 55(11):2457-65. PubMed ID: 24506469
[TBL] [Abstract][Full Text] [Related]
34. Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen.
Ross CW; Schnitzer B; Sheldon S; Braun DK; Hanson CA
Am J Clin Pathol; 1994 Sep; 102(3):310-5. PubMed ID: 8085554
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric features of angioimmunoblastic T-cell lymphoma.
Chen W; Kesler MV; Karandikar NJ; McKenna RW; Kroft SH
Cytometry B Clin Cytom; 2006 May; 70(3):142-8. PubMed ID: 16572417
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic and molecular characterization of a hepatosplenic T-cell lymphoma: report of a novel chromosomal aberration.
Mandava S; Sonar R; Ahmad F; Yadav AK; Chheda P; Ramani M; Gupta AD; Das BR
Cancer Genet; 2011 Feb; 204(2):103-7. PubMed ID: 21504708
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India.
Patkar N; Nair S; Alex AA; Parihar M; Manipadam MT; Arora N; Ahmed R; Abraham A; George B; Viswabandya A; Srivastava V; Srivastava A; Mathews V
Leuk Lymphoma; 2012 Apr; 53(4):609-15. PubMed ID: 21916832
[TBL] [Abstract][Full Text] [Related]
38. [Cell morphological analysis of hepatosplenic T-cell lymphoma gamma-delta type].
Wu P; Sun HP; Wan LJ; Zhou CY; Wang T; Liu HX; Wang H
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(23):1805-1811. PubMed ID: 32536127
[No Abstract] [Full Text] [Related]
39. In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.
Aldinucci D; Poletto D; Zagonel V; Rupolo M; Degan M; Nanni P; Gattei V; Pinto A
Br J Haematol; 2000 Jul; 110(1):188-96. PubMed ID: 10930997
[TBL] [Abstract][Full Text] [Related]
40. Hepatosplenic T-cell lymphoma diagnosed using flow cytometry. A single-center study of 12 cases from North India.
Rahman K; Gupta T; Gupta R; Singh L; Chandra D; Sarkar MK; Singh MK; Kumar S; Nityanand S
J Cancer Res Ther; 2022; 18(4):1093-1097. PubMed ID: 36149166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
